All Articles

A new UK-based quantum testbed allows users to swap hardware and software on the fly, promising faster innovation and a better return on investment.

As RIA consolidation heats up, a recent $625M deal highlights a shift from pure valuation to deep cultural alignment, setting a new precedent for M&A.

Facing a crisis in patient access, Inizio unveils a next-gen hub using integrated analytics and pharmacy services to streamline the path to therapy.

Amid a regulatory crackdown on toxic 'forever chemicals,' one company's strategic acquisition aims to dominate the future of firefighting from homes to industry.

With AI futurist Steve Brown and its new v3.0 platform, Dynamo University 2026 offers a practical roadmap for GPs and LPs to master AI workflows.

Global law firm Freshfields is deploying Anthropic's Claude AI to 5,700 staff, a landmark move signaling a new era of tech-driven competition for legal giants.

A new ketamine clinic in Norfolk targets the region's veteran mental health crisis, offering innovative therapies amid a shifting national landscape.

Omni lands $120M in Series C funding, reaching a $1.5B valuation by tackling the AI accuracy gap with its governed, context-aware analytics platform.

A Montreal agency’s innovative campaign for DEX4 is changing the conversation around hypoglycemia by turning a moment of anxiety into an act of empowerment.

Davidson Hospitality Group will manage a historic Utah resort's massive revamp, blending its unique heritage and geothermal crater with modern luxury amenities.

Football legend Luis Figo is the new face of TenTrade, but the deal highlights growing scrutiny over celebrity endorsements of high-risk finance.

A new clinical study reveals a formula that reduces muscle soreness, boosts mental energy, and improves sleep with surprisingly low doses of key ingredients.

New partnership combines Spotline's regulatory automation with SAS Viya to help pharma and biotech move to the cloud faster and with less compliance risk.

Honoring a legacy of growth, Orchestra Lumos expands its mission from the concert hall to hospitals and schools, backed by vital community partnerships.

Aflac is the American Cancer Society's Partner of the Year, a recognition highlighting its deep commitment as 90% of Americans delay vital screenings.

A new T-cell therapy, RPTR-1-201, enters clinical trials, offering hope for hard-to-treat solid tumors by targeting a shared, multi-cancer marker.

A unique window to experience Denali's serene backcountry before crowds return headlines a season of new adventures and deep cultural immersion in Alaska.

After a year of massive write-downs, the consumer goods giant charts a new course focused on growth, debt reduction, and operational resilience.

A German startup is bringing light-based processors to the US, promising to slash AI's massive energy use. Can photonic computing reshape the future of tech?

A new partnership brings a real-time, shared intelligence network to credit unions, leveling the playing field against AI-driven financial crime.